Dr. Roland Seiler presented an analysis of how different bladder cancer molecular subtypes respond to neoadjuvant chemotherapy at the 2017 ASCO Genitourinary Cancer Symposium.
Roland Seiler
Advertisement
Articles by Roland Seiler
Advertisement
Latest Updated Articles
Analyzing Various Molecular Subtypes in Bladder CancerFebruary 22nd 2017
Advertisement
Advertisement
Trending on CancerNetwork
1
Investigational Radioenhancer Shows Feasibility in Stage III NSCLC
2
Alpha DaRT Overcomes Anatomical Constraints in Inoperable Pancreatic Cancer
3
101 Patient-Reported Outcomes (PROs) in Patients With ER+, HER2- Advanced Breast Cancer (ABC) Treated with Imlunestrant, Investigator’s Choice Standard Endocrine Therapy, or Imlunestrant+Abemaciclib: Results From the Phase III EMBER-3 Trial
4
Fianlimab Combo Does Not Significantly Improve PFS in Advanced Melanoma
5